TACROLIMUS, 98%, 10mg

tert-Butyl 3,9-diazabicyclo[3.3.1]nonane-3-carboxylate, 97%, 100mg

N-(2-(2-(2-(3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 90%, 1g

((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane, 97%, 1g

Diethyl 2-oxoheptane-1,7-dicarboxylate, 97.0%, 1g

ETHYL 2-(2-CHLOROPHENYL)-2-CYANOACETATE, 95.0%, 1g

Dimethyl-2,4-dihydroxyphenylsulfonium chloride, 99.0%, 1g

Ethyl 3-chloroimidazo[1,5-a]pyridine-1-carboxylate, 95.0%, 100mg

Furan-2,5-dicarbaldehyde, 95.0%, 1g

(S)-2-Amino-2-(thiophen-3-yl)ethan-1-ol, 98%, 250mg

Boc-l-2-Fluorophenylalanine, 99.0%, 25g

N-FMOC-L-ASPARTIC ACID 1-(9-FLUORENYLMETHYL) ESTER, 95%, 250mg

Oculaire HWF 10x/22 avec échelle 10 mm/100 micromètres